Andi K. Cani

2.0k total citations
32 papers, 1.1k citations indexed

About

Andi K. Cani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andi K. Cani has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Andi K. Cani's work include Cancer Genomics and Diagnostics (8 papers), Prostate Cancer Treatment and Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Andi K. Cani is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Prostate Cancer Treatment and Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Andi K. Cani collaborates with scholars based in United States, Austria and Italy. Andi K. Cani's co-authors include Scott A. Tomlins, Daniel H. Hovelson, Chia‐Jen Liu, Andrew S. McDaniel, Rork Kuick, Celso E. Gómez-Sánchez, Michael A. Edwards, Thomas J. Giordano, Kazutaka Nanba and William E. Rainey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Andi K. Cani

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andi K. Cani United States	17	384	337	273	230	223	32	1.1k
Janusz Kopczyński Poland	18	453 1.2×	367 1.1×	240 0.9×	194 0.8×	293 1.3×	78	1.4k
Husain A. Saleh United States	19	275 0.7×	279 0.8×	188 0.7×	169 0.7×	156 0.7×	57	915
Mauro Papotti Italy	15	287 0.7×	367 1.1×	142 0.5×	90 0.4×	262 1.2×	24	937
Zahid Kaleem United States	21	270 0.7×	352 1.0×	329 1.2×	418 1.8×	99 0.4×	49	1.3k
Soo Kee Min South Korea	16	181 0.5×	309 0.9×	219 0.8×	170 0.7×	74 0.3×	58	744
Luc Bron Switzerland	19	591 1.5×	886 2.6×	501 1.8×	125 0.5×	114 0.5×	30	1.7k
Wook Youn Kim South Korea	16	122 0.3×	403 1.2×	233 0.9×	354 1.5×	169 0.8×	49	925
Guhyun Kang South Korea	19	275 0.7×	324 1.0×	193 0.7×	188 0.8×	139 0.6×	64	921
Younghye Kim South Korea	13	242 0.6×	251 0.7×	247 0.9×	180 0.8×	235 1.1×	30	817
Alessia Caleo Italy	15	227 0.6×	310 0.9×	271 1.0×	178 0.8×	471 2.1×	38	950

Countries citing papers authored by Andi K. Cani

Since Specialization

Citations

This map shows the geographic impact of Andi K. Cani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andi K. Cani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andi K. Cani more than expected).

Fields of papers citing papers by Andi K. Cani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andi K. Cani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andi K. Cani. The network helps show where Andi K. Cani may publish in the future.

Co-authorship network of co-authors of Andi K. Cani

This figure shows the co-authorship network connecting the top 25 collaborators of Andi K. Cani. A scholar is included among the top collaborators of Andi K. Cani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andi K. Cani. Andi K. Cani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cani, Andi K. & Daniel F. Hayes. (2024). Breast Cancer Circulating Tumor Cells: Current Clinical Applications and Future Prospects. Clinical Chemistry. 70(1). 68–80. 21 indexed citations

Jacob, Jennifer B., Gerold Bepler, Joyce Reyes, et al.. (2023). Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model. iScience. 26(4). 106320–106320. 3 indexed citations

Cani, Andi K., Chia‐Jen Liu, Elizabeth P. Darga, et al.. (2023). Abstract P4-02-04: Serial monitoring of circulating tumor cells and circulating tumor DNA in metastatic lobular breast cancer identifies intra-tumor heterogeneity and precision and immuno-oncology biomarkers of therapeutic importance. Cancer Research. 83(5_Supplement). P4–2. 1 indexed citations

Balikov, Daniel A., Kevin Hu, Bryan L. Betz, et al.. (2021). Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. International Journal of Molecular Sciences. 22(18). 9992–9992. 8 indexed citations

Vince, Randy, Judith Stangl‐Kremser, C. T. Russell, et al.. (2021). Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature. European Urology Oncology. 5(1). 92–99. 8 indexed citations

Cani, Andi K., Daniel A. Balikov, Bryan L. Betz, et al.. (2021). Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy. International Journal of Molecular Sciences. 22(11). 6099–6099. 2 indexed citations

Vega, Lorena Lazo de la, Jonathan B. McHugh, Andi K. Cani, et al.. (2017). Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications. Molecular Cancer Research. 15(11). 1551–1557. 29 indexed citations

Palapattu, Ganesh S., Simpa S. Salami, Andi K. Cani, et al.. (2016). Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer. Clinical Cancer Research. 23(4). 985–991. 17 indexed citations

Harms, Paul W., Angela M. B. Collie, Daniel H. Hovelson, et al.. (2016). Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Modern Pathology. 29(3). 240–248. 77 indexed citations

10.

Vega, Lorena Lazo de la, Daniel H. Hovelson, Andi K. Cani, et al.. (2016). Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss. Human Pathology. 58. 161–170. 11 indexed citations

11.

Harms, Paul W., Daniel H. Hovelson, Andi K. Cani, et al.. (2016). Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations. Human Pathology. 51. 25–31. 34 indexed citations

12.

Rao, Rajesh C., Andi K. Cani, Daniel H. Hovelson, et al.. (2016). Comprehensive Genomic Profiling of Orbital and Ocular Adnexal Lymphomas Identifies Frequent Alterations in MYD88 and Chromatin Modifiers: New Routes to Targeted Therapies. Investigative Ophthalmology & Visual Science. 57(12). 4089–4089. 2 indexed citations

13.

Cani, Andi K., Daniel H. Hovelson, Chia‐Jen Liu, et al.. (2016). Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Modern Pathology. 29(7). 685–697. 49 indexed citations

14.

McDaniel, Andrew S., Daniel H. Hovelson, Andi K. Cani, et al.. (2015). Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy. Cancer Research. 75(24). 5219–5227. 86 indexed citations

15.

Cani, Andi K., Daniel H. Hovelson, Andrew S. McDaniel, et al.. (2015). Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors. Molecular Cancer Research. 13(4). 613–619. 97 indexed citations

16.

Hardiman, Karin M., Peter Ulintz, Rork Kuick, et al.. (2015). Intra-tumor genetic heterogeneity in rectal cancer. Laboratory Investigation. 96(1). 4–15. 54 indexed citations

17.

Kadakia, Kunal C., Scott A. Tomlins, Andi K. Cani, et al.. (2015). Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. Journal of Hematology & Oncology. 8(1). 109–109. 17 indexed citations

18.

Palapattu, Ganesh S., Andi K. Cani, Jiaoti Huang, et al.. (2015). Progression of low- to high-grade prostate cancer: Molecular profiling of tissue obtained by serial targeted biopsy.. Journal of Clinical Oncology. 33(15_suppl). 5017–5017. 1 indexed citations

19.

Hovelson, Daniel H., Andi K. Cani, Andrew S. McDaniel, et al.. (2015). The Oncomine Cancer Research Panel, a scalable next-generation sequencing system for relevant somatic variant assessment in solid tumors.. Journal of Clinical Oncology. 33(15_suppl). e22164–e22164. 1 indexed citations

20.

Warrick, Joshua I., Daniel H. Hovelson, Anmol M. Amin, et al.. (2014). Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(3). 297–311. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact